News

New Atlas2h
Dual-target weight-loss drug is 47% more effective than its rival
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
TCTMD10h
Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
News-Medical.Net on MSN5h
Tirzepatide outperforms semaglutide for weight loss in people without diabetes
A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
Applied Clinical Trials Online15h
Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial
In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...
MedPage Today on MSN10h
Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
The American Journal of Managed Care13d
Access to Semaglutide, Tirzepatide for Obesity Not Equal for All
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York, May 10, 2025 (GLOBE NEWSWIRE) - ...
Us Weekly on MSN3d
The federal ban on generic GLP-1 starts this month. Here's what you can do
If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...